Related by context. All words. (Click for frequent words.) 72 pertuzumab 72 Talabostat 71 ENMD # 71 CBLC# 70 BRAF inhibitor 69 MAGE A3 ASCI 69 mapatumumab 69 Imprime PGG 69 XmAb# 69 sorafenib Nexavar 69 PSMA ADC 69 imetelstat 69 enzastaurin 69 relapsed MM 69 ganetespib 69 receptor tyrosine kinase inhibitor 69 Tarvacin 69 Cloretazine 69 AEG# 69 OXi# 69 Aplidin 68 Symadex 68 depsipeptide 68 OncoVEX 68 alvespimycin 68 tipifarnib 68 regorafenib 68 IMC A# 68 OMP #M# 68 angiogenesis inhibitor 68 PEG SN# 68 YONDELIS 68 milatuzumab 68 Omacetaxine 68 Reverset 68 AKT inhibitor 68 Deforolimus 68 atacicept 68 MET amplification 68 NXL# 68 Traficet EN 68 Xelox 68 lapatinib Tykerb 68 vorinostat 67 elotuzumab 67 investigational humanized monoclonal antibody 67 EndoTAG TM -1 67 antiangiogenic 67 CIMZIA ™ 67 LT NS# 67 galiximab 67 HuMax EGFr 67 neratinib 67 Tyrima 67 Tarvacin TM 67 MEK inhibitors 67 temsirolimus 67 MGd 67 Amrubicin 67 Panzem R NCD 67 Ceflatonin 67 JAK inhibitors 67 thalidomide Thalomid 67 vidofludimus 67 sunitinib malate 67 bendamustine 67 erlotinib Tarceva ® 67 IFN beta 67 HGS ETR1 67 Tarceva TM 67 INCB# [001] 67 docetaxel chemotherapy 67 HGS# 67 Onconase 67 oral antiviral 67 axitinib 67 GRN# 67 sorafenib Nexavar ® 67 Aflibercept 67 Tavocept 67 ATL/TV# 67 preclinically 67 deforolimus 67 DFMO 67 HQK 67 cediranib 67 Phase Ib II 67 GW# [003] 67 Sapacitabine 66 BAY #-# 66 Gleevec resistant 66 CIMZIA TM 66 tyrosine kinase inhibitor 66 goserelin 66 CCX# 66 antithrombotic 66 Nexavar sorafenib 66 CEQ# 66 DXL# 66 dasatinib Sprycel 66 PEGPH# 66 IGF 1R inhibitor 66 gamma secretase inhibitor 66 mTOR inhibitors 66 lenalidomide Revlimid R 66 Elotuzumab 66 evaluating tivozanib 66 PDE4 inhibitor 66 OncoVEX GM CSF 66 PRT# 66 PSN# [002] 66 immune modulating 66 tubulin inhibitor 66 dacetuzumab 66 pegylated liposomal doxorubicin 66 riociguat 66 bicalutamide 66 GRN#L 66 Seliciclib 66 CA4P 66 Proxinium TM 66 Xanafide 66 alkylating agent 66 HER2 positive metastatic breast 66 bortezomib Velcade 66 pomalidomide 66 Pertuzumab 66 azacytidine 66 radezolid 66 Vidofludimus 66 gefitinib Iressa 66 ZD# [001] 66 PXD# 66 docetaxel Taxotere R 66 dasatinib 66 PKC# 66 nucleotide analog 66 rituximab Rituxan 66 Blinatumomab 66 seliciclib 66 Temsirolimus 66 JAK inhibitor 66 HSP# inhibitor 66 Cloretazine R 66 proteasome inhibitors 66 Mipomersen 66 Revlimid lenalidomide 66 pharmacokinetic interactions 66 Carfilzomib 66 ixabepilone 66 antiproliferative effects 66 olaparib 66 anticancer compound 66 reslizumab 66 AP# [003] 66 viral kinetics 66 FK# 66 paclitaxel Taxol 66 Dasatinib 66 metaglidasen 66 romidepsin 66 Teriflunomide 66 Zolinza 65 PROCHYMAL 65 vascular disrupting agent 65 Ocrelizumab 65 Cloretazine ® 65 cytostatic 65 Lenocta 65 proteasome inhibitor 65 PhG alpha 1 65 VNP#M 65 amrubicin 65 protein kinase inhibitor 65 Vitaxin 65 Gefitinib 65 DEB# 65 Archexin 65 Degarelix 65 RhuDex ® 65 antitumoral 65 BRIM2 65 BMS # 65 adecatumumab 65 sulindac 65 sitaxsentan 65 Phase Ib clinical 65 HuLuc# 65 cilengitide 65 signal transduction inhibitor 65 obatoclax 65 farletuzumab 65 chemopreventive agent 65 BCR ABL inhibitor 65 UPLYSO 65 erythropoietic 65 Pazopanib 65 nucleoside analog 65 CCR9 65 HCV replicon 65 Triapine R 65 receptor inhibitor 65 multicenter Phase II 65 ZACTIMA 65 oral rivaroxaban 65 TriRima 65 IFN α 65 Cethromycin 65 trabectedin 65 Bortezomib 65 Sym# 65 bevacizumab Avastin ® 65 OHR/AVR# 65 anti fibrotic 65 idraparinux 65 ELACYT 65 CRLX# 65 EGFR TKI 65 ritonavir boosted 65 TRO# 65 vinca alkaloid 65 adalimumab Humira 65 erlotinib Tarceva 65 recurrent glioblastoma multiforme 65 Amplimexon 65 EZN 65 GAP #B# 65 teriflunomide 65 TG# [003] 65 midstage clinical 65 mertansine 65 Gleevec imatinib mesylate 65 gemcitabine cisplatin 65 iniparib 65 EndoTAGTM 1 65 delafloxacin 65 IMA# 65 forodesine 65 phase IIa clinical 65 favorable pharmacokinetic profile 65 EGFR inhibitors 65 Angiolix 65 tigecycline 65 Olaparib 65 CYT# potent vascular disrupting 65 Alocrest 65 bevacizumab Avastin 65 GRNVAC1 65 imatinib Gleevec ® 65 nab paclitaxel 65 SERMs 65 Velcade bortezomib 65 ImmunoVEX HSV2 65 fosbretabulin 65 anti leukemic 65 Tesmilifene 65 Dapagliflozin 65 ON #.Na 65 HGS ETR2 65 selective inhibition 65 p# inhibitor 64 ASA# 64 Targretin 64 sapacitabine 64 lumiliximab 64 EGFR TKIs 64 Virulizin ® 64 IRX 2 64 Factor VIIa 64 immunomodulator 64 LY# [003] 64 huC# DM4 64 phase IIb trial 64 histone deacetylase inhibitor 64 Aliskiren 64 GLPG# 64 oral prodrug 64 estramustine 64 Panzem 64 Pathway Inhibitor 64 investigational protease inhibitor 64 ACZ# 64 anti CD3 antibody 64 cathepsin K inhibitor 64 motesanib 64 posaconazole 64 mTOR mammalian target 64 radiation sensitizer 64 Phase Ib study 64 VAPRISOL 64 EOquin TM 64 complete cytogenetic response 64 VEGF inhibitors 64 xenograft models 64 imatinib Gleevec 64 alefacept 64 PI3K/Akt pathway inhibitor 64 sorafenib tablets 64 insulin sensitizing 64 ATL# [001] 64 IAP inhibitor 64 docetaxel Taxotere 64 YONDELIS R 64 selective modulator 64 investigational monoclonal antibody 64 DOXIL 64 superficial bladder cancer 64 taxane 64 trodusquemine 64 metastatic RCC 64 HDAC inhibition 64 PEG Interferon lambda 64 HGS ETR1 mapatumumab 64 demonstrated antitumor activity 64 HuMax CD# 64 anakinra 64 CCR2 64 CR# vcMMAE 64 TBC# 64 idarubicin 64 MGCD# [001] 64 multitargeted 64 Panzem R 64 eniluracil 64 pharmacodynamic properties 64 antifibrotic 64 investigational HCV polymerase 64 TACI Ig 64 trastuzumab Herceptin R 64 MEK inhibitor 64 metastatic hormone refractory 64 tocilizumab 64 multi kinase inhibitor 64 novel peptide 64 PREZISTA r 64 anticancer agent 64 topotecan 64 trastuzumab Herceptin ® 64 microtubule inhibitor 64 GLP toxicology studies 64 ToGA 64 Vandetanib 64 Vilazodone 64 AQ4N 64 INTELENCE 64 AEGR 64 TELCYTA 64 muraglitazar 64 flavopiridol 64 MyVax R 64 plasma kallikrein 64 Quinamed 64 microtubule targeting 64 standard chemotherapy regimen 64 antidiabetic 64 PI3K inhibitor 64 APOPTONE 64 Epidermal Growth Factor Receptor 64 relapsed multiple myeloma 64 S/GSK# 64 heavily pretreated 64 Erbitux cetuximab 64 GSK# [001] 64 Onrigin 64 SGS# 64 Hedgehog Pathway Inhibitor 64 cytoprotective 64 Exemestane 64 oncolytic virus 64 Thiovir 64 proteasome inhibitor bortezomib 64 figitumumab 64 docetaxel Taxotere ® 64 ISF# 64 Aplidin R 64 cetuximab Erbitux 64 cytokine refractory 64 K ras mutations 64 canakinumab 64 5 HT4 receptor 63 RGB # 63 Azedra 63 pan HDAC inhibitor 63 Cytoxan 63 synthetic retinoid 63 lenalidomide dexamethasone 63 CIMZIA TM certolizumab pegol 63 Annamycin 63 alemtuzumab Campath 63 Aptivus ® 63 CYC# 63 Nexavar ® 63 decitabine 63 CD# monoclonal antibody 63 retapamulin 63 Leukine 63 antibody MAb 63 APTIVUS r 63 abiraterone acetate 63 vemurafenib 63 Darusentan 63 HIF PHI 63 molecularly targeted 63 corticosteroid dexamethasone 63 liposomal formulation 63 atrasentan 63 PARP inhibitor 63 Perifosine 63 Torisel 63 baminercept 63 CTAP# Capsules 63 gemcitabine Gemzar ® 63 PLX# 63 cetuximab Erbitux R 63 Zalypsis 63 TRV# [001] 63 MDV# 63 PrevOnco ™ 63 KRN# 63 MabCampath 63 Lodamin 63 taxane refractory 63 tesmilifene 63 trastuzumab Herceptin 63 velafermin 63 Ramoplanin 63 TPI ASM8 63 immunomodulatory 63 ganaxolone 63 small molecule Hedgehog 63 HuMax CD4 63 Rasagiline 63 EGFr 63 cariprazine 63 TRAIL induced apoptosis 63 TNFα 63 Gemzar ® 63 Enzastaurin 63 rHuPH# 63 AVOREN 63 bortezomib 63 oral JAK1 63 AMN# [001] 63 MYDICAR ® 63 EGFR tyrosine kinase inhibitors 63 metastatic renal cell carcinoma 63 Chemophase 63 zalutumumab 63 Doxil ® 63 Triapine 63 Tesetaxel 63 sipuleucel T 63 relapsed ovarian cancer 63 Atrasentan 63 antiangiogenic therapy 63 cMET 63 immune modulatory 63 Rigel R# 63 mTOR inhibition 63 Genz # 63 ZOLINZA 63 Hsp# inhibition 63 dasatinib Sprycel ® 63 elvitegravir 63 nitazoxanide 63 telaprevir dosed 63 #ME# 63 radiolabeled TM# 63 chemotherapeutic regimen 63 neoadjuvant treatment 63 Bevacizumab 63 Arranon 63 phase Ib 63 anidulafungin 63 virotherapy 63 sunitinib 63 rilonacept 63 RhuDex R 63 EGFR receptor 63 pharmacodynamic markers 63 chemotherapeutic drug 63 FOLFOX chemotherapy 63 tolvaptan 63 rNAPc2 63 IMiDs ® 63 pharmacodynamic effects 63 peginterferon 63 orally bioavailable 63 Irinotecan 63 Pemetrexed 63 selective androgen receptor modulator 63 IMP# 63 mRCC 63 potent antiproliferative 63 Tarceva erlotinib 63 sargramostim 63 antiangiogenic agents 63 trastuzumab DM1 63 plasma kallikrein inhibitor 63 antimetabolite 63 overlapping toxicities 63 doripenem 63 IGF IR 63 PROSTVAC TM 63 MYCAMINE 63 ALK inhibitors 63 glufosfamide 63 liposomal doxorubicin 63 novel VDA molecule 63 antiangiogenesis 63 nucleoside analogs 63 Curaxin CBLC# 63 Elvitegravir 63 Cetrorelix pamoate 63 lomitapide 63 Ceflatonin R 63 mycophenolate mofetil 63 NEUGENE 63 orally administered inhibitor 63 PD LID 63 Afatinib 63 AMD# [003] 63 GMX# 63 CANCIDAS 63 LymphoStat B belimumab 63 tipranavir 63 selective kinase inhibitor 63 potent topoisomerase II 63 SNT MC# 63 T#I [002] 63 Bezielle 63 Belerofon 63 refractory metastatic 63 vismodegib 63 IMC #B 63 acadesine 63 angiogenesis inhibition 63 incyclinide 62 SCH # 62 entinostat 62 MyVax 62 DAPT 62 cetuximab Erbitux ® 62 Phase IIb clinical trials 62 Pralatrexate 62 Talactoferrin 62 rBChE 62 TRISENOX 62 antiviral efficacy 62 daptomycin 62 immunomodulating 62 fluoropyrimidine 62 Fulvestrant 62 maximally tolerated dose 62 OncoVex 62 Fludara 62 PegIFN RBV 62 vascular disrupting agents 62 abiraterone 62 rALLy clinical trial 62 Factor Xa inhibitor 62 bronchodilatory 62 carboplatin paclitaxel 62 Sorafenib 62 Phase #b/#a trial 62 intratumoral injection 62 panobinostat 62 tezampanel 62 oral FTY# 62 Anti angiogenic 62 kidney urologic 62 R#/MEM # 62 samalizumab 62 nilotinib Tasigna ® 62 therapeutic monoclonal antibodies 62 Trastuzumab 62 CYT# 62 abatacept Orencia 62 nucleoside analogue 62 effector function 62 Panzem NCD 62 surrogate endpoint 62 Phase III metastatic melanoma 62 midstage trials 62 Rituxan rituximab 62 tumor necrosis 62 IAP inhibitors 62 raltegravir 62 etanercept Enbrel 62 CCR5 antagonist 62 LY# [002] 62 antitumor activity 62 huN# DM1 62 Virulizin R 62 RLY# 62 StemEx 62 Genasense ® 62 preclinical efficacy 62 imatinib therapy 62 Phase 2a trial 62 vandetanib 62 custirsen 62 solithromycin 62 JAK2 inhibitor 62 apremilast 62 HCQ 62 targeting CD# 62 gemcitabine Gemzar 62 Cloretazine R VNP#M 62 oblimersen 62 Muraglitazar 62 Vidaza azacitidine 62 IL# PE#QQR 62 Cytolin R 62 dose escalation Phase 62 #I TM# 62 imatinib 62 fenretinide 62 PSN# [001] 62 otelixizumab 62 Eribulin 62 concurrent chemoradiation 62 Squalamine 62 odanacatib 62 mGluR2 NAM 62 fulvestrant 62 REP# 62 anti angiogenic therapy 62 PrevOnco 62 Tykerb lapatinib 62 G#DT 62 antitumor effects 62 interferon IFN 62 sorafenib Nexavar R 62 deacetylase inhibitors 62 EGF receptor 62 mecamylamine 62 Protexia R 62 elesclomol 62 Oral NKTR 62 somatostatin analog 62 JAK3 62 chemoresistant 62 CDK inhibitor 62 dexamethasone Decadron 62 Cloretazine VNP#M 62 HCV RESPOND 2 62 HCV protease inhibitors 62 A3 adenosine receptor 62 Glufosfamide 62 class mGluR5 inhibitor 62 lesinurad 62 Interferon alpha 62 tremelimumab 62 Vascugel 62 histamine dihydrochloride 62 anti angiogenic agent 62 tafamidis 62 mCRC patients 62 indibulin 62 HDAC inhibitors 62 Jevtana 62 Smac mimetics 62 busulfan 62 Zarnestra 62 antiresorptive 62 Urocidin 62 BAL# [002] 62 compound INCB# 62 taxane chemotherapy 62 TNF alpha inhibitor 62 metastatic colorectal 62 Denufosol 62 orally dosed 62 CG# [003] 62 alpha 2a 62 Pyridorin 62 Bendamustine 62 insulin sensitizers 62 GRNCM1 62 paclitaxel Taxol ® 62 mg kg dose 62 eprotirome 62 Curaxin 62 direct thrombin inhibitors 62 chemotherapeutic 62 biologic therapy 62 AV HALT 62 Daclizumab 62 relapsed MCL 62 Alinia 62 HCD# [002] 62 Doxil 62 vicriviroc 62 nilotinib Tasigna 62 bosutinib 62 crizotinib PF # 62 Valortim R 62 Abiraterone acetate 62 XYOTAX TM 62 T DM1 62 zileuton 62 chemoradiotherapy 62 pathophysiological effects 62 HCV protease inhibitor 62 ara C 62 mTOR kinase 62 BAL# [001] 62 Dacogen decitabine 62 gefitinib 62 ribavirin RBV 62 NVA# 62 antiarrhythmic 62 iclaprim 62 Guanilib 62 antitumor effect 62 Interferon alfa 62 tanespimycin 62 aflibercept 62 Epothilones 62 oral Xeloda 62 Zevalin consolidation 62 chimeric monoclonal antibody 62 CB1 antagonists 62 Exelixis XL# 62 miglustat 62 tramiprosate Alzhemed TM 62 metastatic CRC 62 beta 1a 62 gemcitabine 62 lipid lowering therapies 62 registrational trial 62 Akt activation 62 thrombopoietin 62 Methylnaltrexone 62 clodronate 62 MEK inhibitor RDEA# 62 bleomycin 62 trabedersen 62 anti CD3 62 Exherin TM 62 FOLFOX4 62 ASONEP 62 oxaliplatin Eloxatin 62 imexon 62 metastatic HRPC 62 AMPK activators 62 potent anticancer 62 virus HCV protease inhibitor 62 AZT zidovudine Retrovir 62 relapsed leukemia 62 potent cytotoxic 62 Kahalalide F 62 visilizumab 62 OvaRex MAb 62 Hycamtin 62 protease inhibitor PI 62 boosted protease inhibitor 62 GFT# 62 Novolimus 62 antiangiogenic agent 62 nilotinib 62 TLR9 agonist 62 sorafenib 62 Herceptin trastuzumab 61 hour bronchodilation 61 anticancer activity 61 Tamibarotene 61 CLL SLL 61 nucleoside 61 ziconotide 61 ketolide antibiotic 61 Ixempra 61 ADP receptor antagonist 61 SUTENT ® 61 imatinib mesylate Gleevec 61 endothelin receptor antagonists 61 ONCONASE R 61 Amigal 61 Roche Xeloda 61 IFN gamma 61 Gemcitabine 61 oral antidiabetic 61 platelet inhibitor 61 ATACAND 61 IV Busulfex 61 methylnaltrexone 61 EOquin 61 chemotherapy FOLFOX 61 Zemplar Capsules 61 Immunotherapeutic 61 BZL# 61 erlotinib 61 ZK EPO 61 anti proliferative 61 CCR5 receptor antagonist 61 CLORETAZINE TM VNP#M 61 Intravenous CP 61 trastuzumab DM1 T DM1 61 uric acid lowering 61 HMG CoA reductase inhibitors 61 davunetide intranasal AL 61 azacitidine 61 teplizumab 61 blinded randomized placebo controlled 61 TEMODAL 61 bortezomib Velcade R 61 potent suppressor 61 Davanat 61 adenosine A2A 61 phase IIb clinical 61 Hepatocellular Carcinoma HCC 61 EGFR inhibitor 61 SIR Spheres 61 anti amnesic 61 anti TNF 61 triphendiol 61 Lapatinib 61 Eraxis 61 SAR# [004] 61 Anidulafungin 61 JVRS 61 MabThera rituximab 61 Kepivance 61 DCCR 61 Ozarelix 61 ongoing Phase 1b 61 biologic DMARD 61 Plicera 61 Hedgehog inhibitor 61 inhibit angiogenesis 61 selective orally bioavailable 61 BioNumerik 61 Ataluren 61 Tolvaptan 61 SUTENT 61 immunomodulatory agents 61 anticancer therapeutics 61 EchoCRT 61 dexpramipexole 61 CCR9 antagonist 61 ocrelizumab 61 temozolomide TMZ 61 Ontak 61 VEGF receptor 61 OMP #R# 61 acute leukemias 61 HYLENEX recombinant 61 Actilon 61 eltrombopag 61 histone deacetylase inhibitors 61 Fodosine 61 gemcitabine carboplatin 61 sulodexide 61 targeted antifolate 61 oral antiplatelet agent 61 biliary tract cancer 61 HCV SPRINT 61 rhIGFBP 3 61 ELND# 61 lasofoxifene 61 pradefovir 61 talactoferrin 61 systemic ALCL 61 nucleotide analogue 61 sodium glucose cotransporter 61 CCR1 61 cabazitaxel 61 brivaracetam 61 recurrent GBM 61 Romidepsin 61 darapladib 61 Arikace 61 anticancer therapy 61 NP2 Enkephalin 61 etoposide 61 PKCi 61 assessing T DM1 61 Taxotere docetaxel 61 CGRP 61 trans retinoic acid 61 gemcitabine chemotherapy 61 cyclophosphamide chemotherapy 61 isavuconazole 61 novel histone deacetylase 61 Telcyta 61 Anthim 61 refractory indolent non 61 SCCHN 61 Hematologic 61 REOLYSIN ® 61 bovine thrombin 61 alpha#beta# integrin 61 Aurora Kinase 61 clomipramine 61 paricalcitol 61 cisplatin resistant 61 trastuzumab emtansine T DM1 61 multikinase inhibitor 61 c MET 61 PI3K/mTOR 61 TAXOTERE ® 61 CALGB 61 TTF Therapy 61 Vidaza ® 61 Ambrisentan 61 integrase inhibitor 61 capecitabine Xeloda R 61 cannabinor 61 nanoviricides 61 DAVANAT 61 Sudhir Agrawal D.Phil 61 Akt inhibitor 61 phase IIb 61 CCR5 inhibitor 61 dacarbazine DTIC 61 VELCADE melphalan 61 tolerability profiles 61 tolevamer 61 interferon gamma 1b 61 androgen receptor AR 61 Panitumumab 61 Ophena 61 dihydrofolate reductase 61 telaprevir VX 61 investigational integrase inhibitor 61 anti VEGF 61 H. pylori eradication 61 CALGB # [002] 61 TREANDA 61 epigenetic therapies 61 MNTX 61 DU #b 61 Arimoclomol 61 ceftaroline 61 oxidative stress inducer 61 TNFa 61 ANG# 61 Everolimus 61 systemic antifungal 61 Antiangiogenic 61 Aurora kinase 61 motesanib diphosphate 61 systemically administered 61 avosentan 61 schizophrenia CIAS 61 antisense inhibition 61 adjuvant colon cancer 61 NEUMUNE 61 personalized immunotherapy 61 TRAIL receptor antibodies 61 cortisol synthesis 61 Iressa gefitinib 61 Nilotinib 61 bezafibrate 61 imipenem 61 TLK# 61 PF # [002] 61 uricase 61 adefovir 61 varespladib 61 HCV NS5B polymerase 61 placebo controlled clinical 61 elvucitabine 61 antiinflammatory 61 5 HT2B receptor 61 antiandrogens 61 aldosterone antagonists 61 Maribavir 61 APTIVUS 61 octreotide LAR 61 bone metastasis 61 ISTODAX 61 oncolytic 61 ORENCIA R 61 renal toxicity 61 ACTEMRA TM 61 Neulasta ® 61 immunotoxin 61 Boceprevir 61 VA# [002] 61 Interferon Beta 61 GVAX 61 aleglitazar 61 tyrosine kinase inhibitors 61 Kevetrin ™ 61 nutlin 3a 61 GRASPA ® 61 trastuzumab 61 NPC 1C 61 GAMMAGARD 61 docetaxel 61 cancer immunotherapies 61 pharmacodynamic PD 61 brostallicin 61 5-FU/LV 61 MLN# 61 daunorubicin 61 SinuNase TM